Predictors for chemotherapy-related severe or febrile neutropenia: a review of the clinical literature.
- Published in:
- Journal of Oncology Pharmacy Practice, 2001, v. 7, n. 4, p. 141, doi. 10.1191/1078155201jp084oa
- By:
- Publication type:
- Article
Works matching IS 10781552 AND DT 2001 AND VI 7 AND IP 4
Results: 4
1
2
Alemtuzumab (Campath-1H, Campath®) for the treatment of lymphoid malignancies: chronic lymphocytic leukemia and T-cell prolymphocytic leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2001, v. 7, n. 4, p. 133, doi. 10.1191/1078155201jp082oa
- By:
- Publication type:
- Article
3
Chemotherapy-induced moderate to life-theatening anemia in early-stage breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2001, v. 7, n. 4, p. 127, doi. 10.1191/1078155201jp083oa
- By:
- Publication type:
- Article
4
Capecitabine: a novel, orally administered, tumour-activated treatment for colorectal cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2001, v. 7, n. 4, p. 107, doi. 10.1191/1078155201jp085oa
- By:
- Publication type:
- Article